Skip to Main Content

Publications

Featured Publications

2026

  • Pathogenesis of diffuse large B cell lymphoma proteogenotypes

    Enssle J, Häupl B, Qoku A, Wang B, Wright G, Barrans S, Zhou Y, Care M, Burton C, Gribbin C, Ziello J, Weirather J, Dai Y, Kizhakeyil A, Li X, Phelan J, Kanangat S, Eckert S, Scheich S, Wolf S, Huang D, Jakob J, Perner S, Di Fonzo A, Pape M, Bodach M, Jahn D, Plessmann U, Staiger A, Ott G, Berning P, Lenz G, Hodson D, Kuster B, Schmitz R, Urlaub H, Green M, Melnick A, Tooze R, Mlynarczyk C, Inghirami G, Buettner F, Staudt L, Oellerich T. Pathogenesis of diffuse large B cell lymphoma proteogenotypes. Cancer Cell 2026 PMID: 42242231, DOI: 10.1016/j.ccell.2026.05.008.
    Peer-Reviewed Original Research
  • SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities

    Pelzer B, Meydan C, Spiegel I, Karagiannidis I, Xia M, Teater M, Welter E, Searcy Z, Hilton L, Barisic D, Fong A, Fa P, Sethi S, Isgor I, Fielding J, Karbalayghareh A, Burdette C, Tumuluru S, Debek S, Lee S, Massoni-Badosa R, Durmaz C, Salataj E, Pararajalingam P, Chen Z, Pelzl R, Shah S, Rivas M, Hoehn K, Mlynarczyk C, Isles H, Wang X, Dogan A, Elenitoba-Johnson K, Scott D, Dreval K, Morin R, Leslie C, Puri R, Geri J, Chin C, Chadburn A, Mason C, Reinhardt H, Anguera M, Béguelin W, Venturutti L, Melnick A. SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities. Cancer Discovery 2026, 10.1158/2159-8290.cd-25-1458. PMID: 42013317, PMCID: PMC13197974, DOI: 10.1158/2159-8290.cd-25-1458.
    Peer-Reviewed Original Research

2025

2024

2022

2020

2019

2018

2014

2010